Toggle navigation
LOGO
About TTY
About TTY
Strategic Deployment
About Strategic Deployment
Global Operations
TTY Group
Management
Corporate Executives
Organization
Collaboration and Services
Licensing
Contract Development Manufacturing
PIC/S GMP Business Service
Distribution
Newsroom
Technology Development
Technology Development
Liposomes
Introduction
Pipeline
Microspheres
Introduction
Pipeline
Conventional Products
Introduction
Dosage Form
Formulation Capabilities
Formulation Development
Analytical Development
Process Development
Animal Studies
Functional Excipents
GMP Manufacturing
CMC Preparation
Manufacturing
Manufacturing
Cytotoxic Products
Non-cytotoxic Products
Product Areas
Product Areas
Oncology
Products
About TOT BU
Anti-Infection
Products
About TIT BU
Healthcare
Products
Investors
Investors
Investor Conference
Financials
Monthly Revenues
Financial Statements
Annual Report
Shareholder Services
Dividends
Shareholder's Meeting
List of Major Shareholders
Corporate Governance
Board of Directors
Sustainable Development Committee
Audit Committee
Remuneration Committee
Major Corporate Policies
Internal Audit
IP Management
Information Security
Careers
Careers
Philosophy
Salaries & Benefits
Attractive salary
Excellent benefits
Amicable environment
Positive activities
TTY Seeds
New Comer Socialization
Talent Development Program (TDP)
Join TTY
Professional challenges
Recruitment process
Transportation ways
Industry Academy Cooperation
Sustainability
Sustainability
Sustainability Report
Download
TCFD
SASB
Governance
Environmental
Energy & GHG Emission
Water Management
Air Pollution Control
Waste Management
Toxicity Management
TTY Actions
Social
Cancer Cares
Love for Society
TTY Rice
Awards
Employee Care
Salary & Benefits
Comprehensive Training
Occupational Safety & Health
Epidemic Prevention
Supplier
Supplier Assessment
Cold Chain Management
Contractor Management
En /
繁中
Home
Contact Us
Adverse Drug Reaction Reporting
Tel:
+886-2-26525999
#2420 (TOT Oncology Mr. Huang)
Tel:
+886-2-26525999
#2282 (TIT Intensive Care Mr. Chang)
Tel:
+886-2-26525999
#4275 (KAM Healthcare Ms. Tsai)
Email:
drugsafety@tty.com.tw
Business Contacts
CDMO Service
Tel:
+886-2-27967383
#1255
Email:
J_Lin@tty.com.tw
(Mr. Lin)
International Business Development
Tel:
+886-2-26525999
#2451
Email:
info@tty.com.tw
CMO Service
Tel:
+886-2-26525999
#3244
Email:
cmo@tty.com.tw
Investor Contacts
Investor Relationship
Spokesperson》KC Chang
Tel:
+886-2-26525999
#2339
Email:
KC_Chang@tty.com.tw
Acting Spokesperson》Anna Yin
Tel:
+886-2-26525999
#2364
Email:
Anna_Yin@tty.com.tw
Common Share Transfer Agent and Registrar
Company:Capital Securities Registrar Agency Department
Tel:
+886-2-27023999
Add:B2, 97 Sec. 2, Tun-Hwa S. Road, Taipei City, Taiwan R.O.C.
Website:
http://agency.capital.com.tw
Stakeholder Whistleblowing
Email:
ethical@tty.com.tw
Other Affairs
Email:
info@tty.com.tw
TTY Locations
Headquarter
Tel:
+886-2-26525999
Add:3F., No.3-1, Park St., Nangang Dist., Taipei City 11503, Taiwan R.O.C.
Email:
info@tty.com.tw
Chungli Factory
Tel:
+886-3-4522160
Add:No.838, Sec. 1, Zhonghua Rd., Zhongli Dist, Taoyuan City, Taiwan R.O.C.
Lioudu Factory
Tel:
+886-2-24512466
Add:No. 5, Gongjian W. Rd., Qidu Dist., Keelung, Taiwan R. O. C.
Pharmaceutical Development Center
Tel:
+886-2-27967383
Add:3F., No. 124, Xingshan Rd., Neihu Dist., Taipei City 11469, Taiwan R.O.C.
^
TOP